Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
Top Cited Papers
- 10 January 2008
- journal article
- Published by Elsevier in The Lancet Neurology
- Vol. 7 (2), 129-135
- https://doi.org/10.1016/s1474-4422(08)70001-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Current and future uses of neuroimaging for cognitively impaired patientsThe Lancet Neurology, 2008
- PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosisBrain, 2007
- In VitroCharacterization of Pittsburgh Compound-B Binding to Lewy BodiesJournal of Neuroscience, 2007
- 11 C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degenerationNeurology, 2007
- Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography studyAnnals of Neurology, 2006
- Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humansAnnals of Neurology, 2006
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brainNuclear Medicine and Biology, 2005
- Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-BJournal of Cerebral Blood Flow & Metabolism, 2005
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004